Australia

NEW TO ZOETIS DIRECT? 
LEARN MORE

Glanvac® 3 Vaccine

Expand All
  • Glanvac ®3 provides sheep and goats with protection against Cheesy Gland (CLA), tetanus and pulpy kidney.

    Glanvac® 3 utilises Zoetis' ultra-filtration technology, which selectively removes unwanted particles during the production process. This allows the vaccine to produce a more targeted immune response in sheep and goats, while providing producers with the convenience of a 1mL dose rate.

  • Control of caseous lymphadenitis (CLA); prevention of enterotoxaemia (pulpy kidney disease) and tetanus in sheep, lambs, goats and kids.

    • Maintain a high level of disease protection in the breeding flock for the next 12 months.
    • Improve lamb marking percentages by preventing clostridial deaths such as pulpy kidney.
    • Improve wool quality and quantity by protecting against cheesy gland.
    • Improve meat quality through cheesy gland protection, ensuring export and domestic customers receive a quality product.
  • Subcutaneous injection (plastic pack): 250mL, 500mL

    • Inject 1mL subcutaneously on the side of the neck just behind and below the base of the ear.
    • In previously unvaccinated animals of all ages, give a 1mL dose and repeat 4 weeks later.
    • Give a booster dose of 1mL 12 months after the two initial doses to confer lifelong immunity against tetanus.
    • Give all animals annual booster doses within 6 months prior to shearing to control caseous lymphadenitis (CLA).
    • Where possible give the annual booster prior to the time of maximum risk, e.g. transfer to lush pasture or grain feeding in the case of enterotoxaemia.
    • Pregnant ewes: Give previously unvaccinated animals 1mL at the time of mating; repeat at up to 4 weeks before the expected date of birth. Omit the dose at mating in previously vaccinated animals.
    • Vaccinated pregnant ewes will pass on immunity to their lambs in the colostrum; lambs should be protected for the first 6 to 8 weeks of life.
    • This product can be stored and used for up to 30 days after first opening. On each subsequent reuse, swab the opening with a suitable disinfectant (for example, methylated spirits) both before and after using. A sterile needle must be used each time product is removed. Store unused material upright, at 2°C to 8°C (refrigerated) and in the original cardboard packaging to protect from light.
    • Localised swelling may develop at the injection site and a firm nodular lump may persist for some weeks or even months.
    • Storage
      Store at 2°C to 8°C (refrigerate. Do not freeze.) Protect from light.
    • Withholding period:
      NIL
    • Schedule:
      NIL
A Better Way To Buy